Abstract
Phenylketonuria (PKU) leads to severe neurological disorders in childhood, shunned by the diet. The long-term prognosis after diet diversification at adolescence is uncertain. We report a case of cortical blindness in a young patient regressive 1 month after the diet was resumed.
Mr M., 25 years old, had PKU detected at birth. He maintained good serum levels of Phenylalanine (Phe) (120–300 μmol/L) during childhood and got a normal intellectual development. During adolescence he diversified his diet but maintained low meat and fish intake; Phe was ~1,200 μmol/L with no symptoms. In 2009, the patient stopped the low-Phe amino acid substitutes due to weariness. On June 27, 2011, he consulted for a decrease of visual acuity progressing for 6 months. Ophthalmologic examination found that visual acuity was 2/10 in two eyes associated to a central visual field defect. The visual evoked potentials were altered. MRI showed bilateral and symmetric occipital FLAIR hyperintensities. On admission in the Nutrional Unit on June 29, 2011, blood pressure was 120/70 mmHg, there was no other neurological abnormality. Phe was at 1,512 μmol/L, and not responsive to BH4. He was then treated with a very low-Phe diet with an amino acid substitute, and he obtained Phe between 120 and 300 μmol/L. Visual acuity was suddenly restored on August 1, 2011, with a dramatic attenuation of the MRI hyperintensities.
Our observation shows that the withdrawal of the diet and substitutes exposes to serious neurological complications in adults that may reverse with a fast nutritional support.
Competing interests: None declared
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson PJ, Leuzzi V (2010) White matter pathology in phenylketonuria. Molecular Genetics Metabol 99(S): S3–S9. Elsevier Inc
Blau N, van Spronsen FJ, Levy HL (2010 Oct 23) Phenylketonuria. Lancet 376(9750):1417–1427
de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Molecular Genetics Metabol 99(S):S86–S89. Elsevier Inc
Ishimaru K, Tamasawa N, Baba M, Matsunaga M, Takebe K (1993 Sept) Phenylketonuria with adult-onset neurological manifestation. Rinsho Shinkeigaku 33(9):961–965
Kornguth S, Gilbert-Barness E, Langer E, Hegstrand L (1992 Nov 1) Golgi-Kopsch silver study of the brain of a patient with untreated phenylketonuria, seizures, and cortical blindness. Am J Med Genet 44(4):443–448
Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC et al (1990 Sep 8) Neurological deterioration in young adults with phenylketonuria. Lancet 336(8715):602–605
Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58(6):1145–1156
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Francois Feillet
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rubin, S. et al. (2012). Sight-Threatening Phenylketonuric Encephalopathy in a Young Adult, Reversed by Diet. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Volume 10. JIMD Reports, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_207
Download citation
DOI: https://doi.org/10.1007/8904_2012_207
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37333-6
Online ISBN: 978-3-642-37334-3
eBook Packages: MedicineMedicine (R0)